Latest News

Offshore Wind Sensors – Technology Demonstration

Wideblue project manager Russell Overend will give a talk about Wideblue’s collaborative product development with the Offshore Renewable Energy Catapult on 12th Jan in Fife. Wideblue and ORE Catapult have made good progress on their low cost Blade Optical Health Monitoring System and Russell will give details on their experiences.

To register for the event or for further details click here.

Wideblue Director Grant King to speak at the first Technology Scotland design workshop in Edinburgh on 1st November.

The subject of the talk will be “Design: Taking Ideas to Market”, Grant will focus on the innovation process, the identification of market needs in a technologically advanced world, and how to take products to market that are fit for the end users.

Check the event workshop to find out more.

Wideblue to demonstrate three new products at CENSIS Technology Summit

Wideblue will demonstrate some of the new products they are working on at the Technology Summit being organised by CENSIS on Thurs 6th October at the Technology Innovation Centre in Glasgow. Wideblue plan to demonstrate the new Impossible I-1 camera which uses Polaroid style film, the MAPS automated pipe scanner and the CRiL personal capnometer. Attendees at the Summit will get the chance to get hands on with the technology and ask questions about their own new product ideas.

Wideblue customer CRiL completes clinical trials with great results delivered from NTC1

Wideblue designed and built a batch of N-Tidal C (NTC1) battery powered personal respiratory monitors in January this year. The devices were used in an observational, longitudinal clinical study at Addenbrookes hospital for COPD sufferers at home and in clinic. The study has now been completed and the results are being analysed. The 30 monitors used in the study collected over 2,600 respiratory records containing more than 50,000 individual breaths. The results are very encouraging. Jeremy Walsh (CEO of CRiL) said, “These innovative new medical devices designed and built by Wideblue performed very well during the study. The COPD patients found them intuitive and easy to use. The NTC1s have delivered very high quality respiratory data from the study. Importantly, the data is accurate and repeatable. We believe that our technology will improve the diagnosis, management and treatment of a wide range of respiratory diseases. Our current focus is to transform the management of COPD, Asthma and CHF.”

Wideblue deliver batch of prototype ophthalmoscopes to Peek

Peek Retina – Turns a mobile phone into an ophthalmoscope.

Wideblue recently delivered a first batch of advanced prototypes of Peek Retina to Peek for evaluation in London and Tanzania. The prototype devices have already been used to correctly identify cases of glaucoma and cataract. Next Wideblue will move onto design for manufacture (DFM), assistance with regulatory approvals and set up a manufacturing supply chain for the new medical device.